[1]马远,叶向阳,程省,等.P选择素、抗心磷脂抗体及活化蛋白C抵抗预测下肢创伤骨折术后深静脉血栓形成的临床研究[J].中医正骨,2019,31(08):31-34.
 MA Yuan,YE Xiangyang,CHENG Sheng,et al.Applied value of P-selectin,anticardiolipin antibody and activated protein c resistance in predicting deep venous thrombosis after the surgery for treatment of traumatic lower extremity fractures:a clinical study[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2019,31(08):31-34.
点击复制

P选择素、抗心磷脂抗体及活化蛋白C抵抗预测下肢创伤骨折术后深静脉血栓形成的临床研究()
分享到:

《中医正骨》[ISSN:1001-6015/CN:41-1162/R]

卷:
第31卷
期数:
2019年08期
页码:
31-34
栏目:
临床研究
出版日期:
2019-08-20

文章信息/Info

Title:
Applied value of P-selectin,anticardiolipin antibody and activated protein c resistance in predicting deep venous thrombosis after the surgery for treatment of traumatic lower extremity fractures:a clinical study
作者:
马远叶向阳程省郭雄飞
(南阳市中心医院,河南 南阳 473003)
Author(s):
MA YuanYE XiangyangCHENG ShengGUO Xiongfei
Nanyang Central Hospital,Nanyang 473003,Henan,China
关键词:
静脉血栓形成 下肢骨 骨折 P选择素 抗心磷脂抗体 活化蛋白C抵抗
Keywords:
venous thrombosis bones of lower extremity fracturesbone P-selectin anticardiolipin antibody activated protein c resistance
摘要:
目的:探讨P选择素、抗心磷脂抗体(anticardiolipin antibody,ACA)及活化蛋白C抵抗(activated protein c resistance,APCR)对下肢创伤骨折术后深静脉血栓形成(deep venous thrombosis,DVT)的预测价值。方法:选择接受手术治疗的下肢创伤骨折患者,术后第3天抽取患者静脉血,采用酶联免疫吸附法测定P选择素含量和ACA阳性率,采用Dahlback法测定APCR阳性率。按照《深静脉血栓形成的诊断和治疗指南(第三版)》中DVT的诊断标准判断患者术后2周内是否发生DVT,比较DVT组和无DVT组的血清P选择素含量、血清ACA阳性率及血清APCR阳性率。以是否发生DVT为因变量,以血清P选择素、ACA及APCR为自变量,进行多因素Logistic回归分析。结果:共纳入648例患者,其中31例患者术后2周内发生DVT(DVT组),其余617例均未检出DVT(无DVT组)。2组患者的血清P选择素含量、血清ACA阳性率及血清APCR阳性率比较,差异均有统计学意义(t=26.989,P=0.000; χ2=0.010,P=0.000; χ2=12.447,P=0.000)。多因素Logistic回归分析结果显示,血清P选择素、ACA及APCR是下肢创伤骨折术后DVT的危险因素(OR=1.219,P=0.019; OR=1.292,P=0.009; OR=2.430,P=0.012)。结论:P选择素、ACA及APCR是下肢创伤骨折术后DVT的危险因素,可作为预测下肢创伤骨折术后DVT的检测指标。
Abstract:
Objective:To explore the applied value of P-selectin,anticardiolipin antibody(ACA)and activated protein c resistance(APCR)in predicting deep venous thrombosis(DVT)after the surgery for treatment of traumatic lower extremity fractures.Methods:The patients who received surgery for traumatic lower extremity fractures were selected and their blood was drawn from veins at the 3rd day after surgery.The content of P-selectin and positive rate of ACA were detected by using enzyme-linked immunoadsordent assay,and the positive rate of APCR was detected by using Dahlback method.The patients were divided into DVT group and non-DVT group according to whether DVT was found within 2 weeks after surgery in accordance with the diagnostic standards of DVT which was extracted from Guidelines for Diagnosis and Treatment of Deep Venous Thrombosis(3rd edition).The serum content of P-selectin and positive rate of serum ACA and serum APCR were compared between the 2 groups.The multiple-factor Logistic regression analysis was conducted by chosing occurrence of DVT as the dependent variable and chosing serum P-selectin,ACA and APCR as independent variables.Results:Six hundred and forty-eight patients were included in the study.DVTs were found in 31 patients(DVT group)and unfound in 617 patients(non-DVT group)within 2 weeks after surgery.There was statistical difference in serum content of P-selectin and positive rate of serum ACA and serum APCR between the 2 groups(t=26.989,P=0.000; χ2=0.010,P=0.000; χ2=12.447,P=0.000).The result of multiple-factor Logistic regression analysis demonstrated that the serum P-selectin,ACA and APCR were the risk factors for DVT following the surgery for treatment of traumatic lower extremity fractures(OR=1.219,P=0.019; OR=1.292,P=0.009; OR=2.430,P=0.012).Conclusion:P-selectin,ACA and APCR are the risk factors for DVT following the surgery for treatment of traumatic lower extremity fractures,and they may serve as the detection indicators for the prediction of DVT after the surgery for treatment of traumatic lower extremity fractures.

参考文献/References:

[1] VERSO M,AGNELLI G,AGENO W,et al.Long-term death and recurrence in patients with acute venous thromboembolism:the master registry[J].Thrombosis Research,2012,130(3):369-373.
[2] 卢锌祥,路磊.髋部骨折后下肢深静脉血栓形成的诊断和影响因素及预防措施研究进展[J].中医正骨,2019,31(2):36-38.
[3] 钱涛,夏永法.老年全髋关节置换术中联合应用氨甲环酸和利伐沙班的临床研究[J].中医正骨,2019,31(1):10-13.
[4] 中华医学会外科学分会血管外科学组.深静脉血栓形成的诊断和治疗指南(第三版)[J].中国血管外科杂志(电子版),2017,9(4):250-257.
[5] 王国杰,张灼锦.血浆D-二聚体检测对下肢深静脉血栓的早期诊断价值[J].实用医学杂志,2012,28(14):2368-2370.
[6] 娄振凯,彭志,周如丹,等.P-选择素及P-选择素糖蛋白配体-1在大鼠深静脉血栓模型中的表达变化[J].中国急救医学,2016,36(2):150-154.
[7] 尚小鹏,马金栋,马居风,等.骨创伤后深静脉血栓形成的危险因素分析[J].中华创伤杂志,2012,28(12):1088-1091.
[8] PIOVELLA F,WANG C J,LU H,et al.Deep-vein thrombosis rates after major orthopedic surgery in Asia.An epidemiological study based on postoperative screening with centrally adjudicated bilateral venography[J].J Thromb Haemost,2005,3(12):2664-2670.
[9] 黄攀,何晓英.D-二聚体、P选择素联合检测对急性脑梗死病情及预后判断的价值[J].中国老年学杂志,2018,38(24):27-29.
[10] 张柏根,薛冠华.深静脉血栓形成的病因及高危因素[J].中国实用外科杂志,2003,23(4):197-200.
[11] 张蕴鑫,刘建龙,贾伟,等.P-选择素、溶酶体颗粒糖蛋白、血小板活化因子和血浆D-二聚体水平与下肢深静脉血栓形成的关系[J].中国老年学杂志,2017,37(5):1221-1223.
[12] 董嘉尧,罗美华,周成宇,等.P-选择素与深静脉血栓的相关性研究进展[J].海南医学,2016,27(8):1285-1288.
[13] 杜志强,郝斌,曹文东,等.抗磷脂抗体促血栓形成的机制[J].中日友好医院学报,2011,25(4):244-246.
[14] 贺颖,连建华,齐华,等.深静脉血栓患者外周血抗心磷脂抗体水平测定[J].郑州大学学报(医学版),2002,37(3):313-315.
[15] KEARON C,PARPIA S,SPENCER F A,et al.Antiphospholipid antibodies and recurrent thrombosis after a first unprovoked venous thromboembolism[J].Blood,2018,131(19):2151-2160.
[16] MALEC K,GRALCZYK T,UNDAS A.The use of direct oral anticoagulants in 56 patients with antiphospholipid syndrome[J].Thromb Res,2017,152:93-97.
[17] CARVALHO J F,ANDRADE D C,LEVY R A.Direct oral anticoagulants in antiphospholipid syndrome[J].Rev Bras Reumatol Engl Ed,2016,56(6):469-470.
[18] 陈浩,肖占祥,戚悠飞,等.海南地区静脉血栓栓塞症患者活化蛋白C抵抗与凝血因子V基因多态性研究[J].第三军医大学学报,2018,40(20):86-89.
[19] 高丽霞,丁秋兰,吴克雄,等.血栓及血栓前状态与凝血因子V基因多态性和APCR及HHcy的相关性研究[J].中国实验血液学杂志,2016,24(6):1850-1855.
[20] FUJI T,AKAGI M,ABE Y,et al.Incidence of venous thromboembolism and bleeding events in patients with lower extremity orthopedic surgery:a retrospective analysis of a Japanese healthcare database[J].J Orthop Surg Res,2017,12(1):55.

相似文献/References:

[1]夏海波,蒋李青,兰俊,等.负压封闭引流技术在下肢开放性骨折骨外露治疗中的应用[J].中医正骨,2018,30(08):60.
[2]史炎鑫,海国栋,窦浚峰.Ilizarov骨搬移术治疗下肢骨肿瘤切除术后骨缺损[J].中医正骨,2019,31(10):63.
[3]周晓聪,丁玉梅,周前,等.补阳还五汤加减联合利伐沙班预防老年髋关节置换术后深静脉血栓形成的疗效观察及作用机制研究[J].中医正骨,2020,32(10):35.
 ZHOU Xiaocong,DING Yumei,ZHOU Qian,et al.A clinical study on the curative effects and mechanism of action of oral applications of Buyang Huanwu Tang Jiajian(补阳还五汤加减)and Rivaroxaban for preventing deep venous thrombosis after the surgery of hip replacement in the aged[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2020,32(08):35.
[4]孟祥亚,马士超,陈秀民.加味桂枝茯苓丸口服联合低分子量肝素钙皮下注射预防全膝关节置换术后气滞血瘀证患者深静脉血栓形成的临床研究[J].中医正骨,2023,35(12):30.
 MENG Xiangya,MA Shichao,CHEN Xiumin.[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2023,35(08):30.

备注/Memo

备注/Memo:
通讯作者:叶向阳 E-mail:yexyang2008@163.com(收稿日期:2019-06-10 本文编辑:李晓乐)
更新日期/Last Update: 2019-08-15